婴儿和儿童疫苗接种后IgG水平的性别差异:疫苗接种研究的个体参与者数据荟萃分析
该研究系统再分析荷兰6项儿童疫苗接种研究(1577名儿童),采用个体参与者数据荟萃分析评估性别对肺炎球菌、白喉类毒素、破伤风类毒素、百日咳和Hib-PRP的IgG水平的影响。结果显示大多数疫苗抗原的IgG水平无一致性别差异,仅肺炎球菌IgG水平在女孩中从基础免疫后至11月龄加强前轻度升高,且反应原性和疫苗失败/效果无性别差异,支持荷兰国家免疫规划的统一婴儿疫苗接种程序。
要点
- 女孩与男孩的肺炎球菌IgG几何平均浓度比在基础免疫后1个月为1.15(95%CI 0.91-1.45),8月龄为1.16(1.02-1.32),11月龄加强前为1.12(1.02-1.23),12月龄加强后为0.99(0.89-1.10)。
- 白喉类毒素、破伤风类毒素、百日咳Ptx/FHA/Prn和Hib-PRP的IgG水平在两性间无差异,除外Hib加强后(1.24;95%CI 1.01-1.52)和学龄前加强前破伤风(0.71;0.53-0.95)。
- 4月龄或11月龄反应原性及侵袭性肺炎球菌病、侵袭性Hib病或百日咳的疫苗失败/效果在两性间无差异。
核心结论
- 对于大多数研究的疫苗抗原,疫苗诱导的IgG水平无一致性别差异;疫苗诱导的肺炎球菌IgG水平在女孩中略高,但仅在基础免疫后至11月龄加强前期间;结合相似的反应原性和疫苗失败/效果,支持荷兰国家免疫规划的统一婴儿疫苗接种程序。
研究设计与样本
- 系统再分析荷兰6项儿童疫苗接种研究,纳入1577名儿童,采用一阶段个体参与者数据荟萃分析,按时间点使用线性混合模型评估性别对IgG水平的影响。
主要发现
- 女孩与男孩的肺炎球菌IgG几何平均浓度比(合并血清型)在基础免疫后1个月为1.15(95%CI 0.91-1.45),8月龄为1.16(1.02-1.32),11月龄加强前为1.12(1.02-1.23),12月龄加强后为0.99(0.89-1.10)。
- 白喉类毒素、破伤风类毒素、百日咳Ptx/FHA/Prn和Hib-PRP的IgG水平在两性间无差异,除外Hib加强后(1.24;95%CI 1.01-1.52)和学龄前加强前破伤风(0.71;0.53-0.95)。
- 4月龄或11月龄反应原性及侵袭性肺炎球菌病、侵袭性Hib病或百日咳的疫苗失败/效果在两性间无差异。
关键数值与推荐
- 女孩与男孩肺炎球菌IgG几何平均浓度比在基础免疫后1个月为1.15(95%CI 0.91-1.45),8月龄为1.16(1.02-1.32),11月龄加强前为1.12(1.02-1.23),12月龄加强后为0.99(0.89-1.10)。
- Hib加强后女孩与男孩IgG几何平均浓度比为1.24(95%CI 1.01-1.52),学龄前加强前破伤风为0.71(0.53-0.95)。
- 白喉类毒素、百日咳Ptx/FHA/Prn及Hib基础免疫后IgG水平在两性间无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: If immune responses to vaccination differ between males and females, sex-specific vaccination schedules may be indicated. We systematically reanalysed childhood vaccination studies conducted in The Netherlands for sex-differences in IgG-responses. To assess the impact of potential sex-differences in IgG-responses, we explored sex-differences in vaccine failure/effectiveness and reactogenicity. METHODS: Six studies with IgG-measurements for 1577 children following infant pneumococcal (PCV7/PCV10/PCV13) and/or DTaP-IPV-Hib(-HepB) vaccinations, or the pre-school DTaP-IPV booster were included. We performed one-stage individual participant data meta-analyses per time-point of the effect of sex on IgG levels against pneumococcal serotypes, diphtheria toxoid, tetanus toxoid, pertussis Ptx/FHA/Prn and Hib-PRP using linear mixed models. Using existing study data, we compared reactogenicity after PCV7/PCV10 and DTaP-IPV-Hib(-HepB) vaccination in girls and boys. Vaccine failure/effectiveness was compared between girls and boys for invasive pneumococcal disease (IPD), invasive Hib disease and pertussis using notification data. RESULTS: For pneumococcal vaccination, the geometric mean concentration ratio of IgG levels in girls versus boys pooled across serotypes was 1.15 (95%CI 0.91-1.45) 1 month following the primary series, 1.16 (1.02-1.32) at age 8 months, 1.12 (1.02-1.23) pre-booster (age 11 months) and 0.99 (0.89-1.10) post-booster (age 12 months). Diphtheria toxoid, tetanus toxoid, pertussis Ptx/FHA/Prn and Hib-PRP IgG levels did not differ between girls and boys, except for Hib post-booster (1.24; 95%CI 1.01-1.52) and tetanus before pre-school booster (0.71; 0.53-0.95). We found no difference between boys and girls in reactogenicity at age 4 or 11 months or in vaccine failure/effectiveness for IPD, invasive Hib disease or pertussis. CONCLUSION: For most vaccine antigens investigated, there were no consistent differences in vaccine-induced IgG levels. Vaccine-induced pneumococcal IgG levels were slightly higher in girls, but only between the primary series and the 11-month booster. These results, along with similar reactogenicity and vaccine failure/effectiveness, support the uniform infant vaccination schedule in the Dutch national immunisation programme.
引用
- Boef AGC, van der Klis FRM, Berbers GAM, et al. Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies. Vaccine. 2017. PMID: 29223483. doi:10.1016/j.vaccine.2017.11.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。